1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Neuromuscular Disease
1.2.3 Genetic Disease
1.2.4 Other
1.3 Market by Application
1.3.1 Global Gene Therapy Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Drugs Market Perspective (2017-2028)
2.2 Gene Therapy Drugs Growth Trends by Region
2.2.1 Gene Therapy Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Gene Therapy Drugs Historic Market Size by Region (2017-2022)
2.2.3 Gene Therapy Drugs Forecasted Market Size by Region (2023-2028)
2.3 Gene Therapy Drugs Market Dynamics
2.3.1 Gene Therapy Drugs Industry Trends
2.3.2 Gene Therapy Drugs Market Drivers
2.3.3 Gene Therapy Drugs Market Challenges
2.3.4 Gene Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Drugs Players by Revenue
3.1.1 Global Top Gene Therapy Drugs Players by Revenue (2017-2022)
3.1.2 Global Gene Therapy Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Drugs Revenue
3.4 Global Gene Therapy Drugs Market Concentration Ratio
3.4.1 Global Gene Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Drugs Revenue in 2021
3.5 Gene Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Gene Therapy Drugs Product Solution and Service
3.7 Date of Enter into Gene Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Drugs Breakdown Data by Type
4.1 Global Gene Therapy Drugs Historic Market Size by Type (2017-2022)
4.2 Global Gene Therapy Drugs Forecasted Market Size by Type (2023-2028)
5 Gene Therapy Drugs Breakdown Data by Application
5.1 Global Gene Therapy Drugs Historic Market Size by Application (2017-2022)
5.2 Global Gene Therapy Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Gene Therapy Drugs Market Size (2017-2028)
6.2 North America Gene Therapy Drugs Market Size by Type
6.2.1 North America Gene Therapy Drugs Market Size by Type (2017-2022)
6.2.2 North America Gene Therapy Drugs Market Size by Type (2023-2028)
6.2.3 North America Gene Therapy Drugs Market Share by Type (2017-2028)
6.3 North America Gene Therapy Drugs Market Size by Application
6.3.1 North America Gene Therapy Drugs Market Size by Application (2017-2022)
6.3.2 North America Gene Therapy Drugs Market Size by Application (2023-2028)
6.3.3 North America Gene Therapy Drugs Market Share by Application (2017-2028)
6.4 North America Gene Therapy Drugs Market Size by Country
6.4.1 North America Gene Therapy Drugs Market Size by Country (2017-2022)
6.4.2 North America Gene Therapy Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gene Therapy Drugs Market Size (2017-2028)
7.2 Europe Gene Therapy Drugs Market Size by Type
7.2.1 Europe Gene Therapy Drugs Market Size by Type (2017-2022)
7.2.2 Europe Gene Therapy Drugs Market Size by Type (2023-2028)
7.2.3 Europe Gene Therapy Drugs Market Share by Type (2017-2028)
7.3 Europe Gene Therapy Drugs Market Size by Application
7.3.1 Europe Gene Therapy Drugs Market Size by Application (2017-2022)
7.3.2 Europe Gene Therapy Drugs Market Size by Application (2023-2028)
7.3.3 Europe Gene Therapy Drugs Market Share by Application (2017-2028)
7.4 Europe Gene Therapy Drugs Market Size by Country
7.4.1 Europe Gene Therapy Drugs Market Size by Country (2017-2022)
7.4.2 Europe Gene Therapy Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Drugs Market Size (2017-2028)
8.2 Asia-Pacific Gene Therapy Drugs Market Size by Type
8.2.1 Asia-Pacific Gene Therapy Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Gene Therapy Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Gene Therapy Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Gene Therapy Drugs Market Size by Application
8.3.1 Asia-Pacific Gene Therapy Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Gene Therapy Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Gene Therapy Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Gene Therapy Drugs Market Size by Region
8.4.1 Asia-Pacific Gene Therapy Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Gene Therapy Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy Drugs Market Size (2017-2028)
9.2 Latin America Gene Therapy Drugs Market Size by Type
9.2.1 Latin America Gene Therapy Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Gene Therapy Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Gene Therapy Drugs Market Share by Type (2017-2028)
9.3 Latin America Gene Therapy Drugs Market Size by Application
9.3.1 Latin America Gene Therapy Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Gene Therapy Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Gene Therapy Drugs Market Share by Application (2017-2028)
9.4 Latin America Gene Therapy Drugs Market Size by Country
9.4.1 Latin America Gene Therapy Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Gene Therapy Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Drugs Market Size (2017-2028)
10.2 Middle East & Africa Gene Therapy Drugs Market Size by Type
10.2.1 Middle East & Africa Gene Therapy Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Gene Therapy Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Gene Therapy Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Gene Therapy Drugs Market Size by Application
10.3.1 Middle East & Africa Gene Therapy Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Gene Therapy Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Gene Therapy Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Gene Therapy Drugs Market Size by Country
10.4.1 Middle East & Africa Gene Therapy Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Gene Therapy Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche AG
11.1.1 F. Hoffmann-La Roche AG Company Details
11.1.2 F. Hoffmann-La Roche AG Business Overview
11.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Introduction
11.1.4 F. Hoffmann-La Roche AG Revenue in Gene Therapy Drugs Business (2017-2022)
11.1.5 F. Hoffmann-La Roche AG Recent Developments
11.2 Novartis International AG
11.2.1 Novartis International AG Company Details
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Gene Therapy Drugs Introduction
11.2.4 Novartis International AG Revenue in Gene Therapy Drugs Business (2017-2022)
11.2.5 Novartis International AG Recent Developments
11.3 Gilead Sciences, Inc.
11.3.1 Gilead Sciences, Inc. Company Details
11.3.2 Gilead Sciences, Inc. Business Overview
11.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Introduction
11.3.4 Gilead Sciences, Inc. Revenue in Gene Therapy Drugs Business (2017-2022)
11.3.5 Gilead Sciences, Inc. Recent Developments
11.4 Ultragenyx Pharmaceutical?Inc.
11.4.1 Ultragenyx Pharmaceutical?Inc. Company Details
11.4.2 Ultragenyx Pharmaceutical?Inc. Business Overview
11.4.3 Ultragenyx Pharmaceutical?Inc. Gene Therapy Drugs Introduction
11.4.4 Ultragenyx Pharmaceutical?Inc. Revenue in Gene Therapy Drugs Business (2017-2022)
11.4.5 Ultragenyx Pharmaceutical?Inc. Recent Developments
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Details
11.5.2 Applied Genetic Technologies Corp Business Overview
11.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Introduction
11.5.4 Applied Genetic Technologies Corp Revenue in Gene Therapy Drugs Business (2017-2022)
11.5.5 Applied Genetic Technologies Corp Recent Developments
11.6 Audentes Therapeutics
11.6.1 Audentes Therapeutics Company Details
11.6.2 Audentes Therapeutics Business Overview
11.6.3 Audentes Therapeutics Gene Therapy Drugs Introduction
11.6.4 Audentes Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
11.6.5 Audentes Therapeutics Recent Developments
11.7 BioMarin Pharmaceutical
11.7.1 BioMarin Pharmaceutical Company Details
11.7.2 BioMarin Pharmaceutical Business Overview
11.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Introduction
11.7.4 BioMarin Pharmaceutical Revenue in Gene Therapy Drugs Business (2017-2022)
11.7.5 BioMarin Pharmaceutical Recent Developments
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Gene Therapy Drugs Introduction
11.8.4 Bluebird Bio Revenue in Gene Therapy Drugs Business (2017-2022)
11.8.5 Bluebird Bio Recent Developments
11.9 Nightstar Therapeutics
11.9.1 Nightstar Therapeutics Company Details
11.9.2 Nightstar Therapeutics Business Overview
11.9.3 Nightstar Therapeutics Gene Therapy Drugs Introduction
11.9.4 Nightstar Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
11.9.5 Nightstar Therapeutics Recent Developments
11.10 Sangamo Therapeutics
11.10.1 Sangamo Therapeutics Company Details
11.10.2 Sangamo Therapeutics Business Overview
11.10.3 Sangamo Therapeutics Gene Therapy Drugs Introduction
11.10.4 Sangamo Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
11.10.5 Sangamo Therapeutics Recent Developments
11.11 Spark Therapeutics
11.11.1 Spark Therapeutics Company Details
11.11.2 Spark Therapeutics Business Overview
11.11.3 Spark Therapeutics Gene Therapy Drugs Introduction
11.11.4 Spark Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
11.11.5 Spark Therapeutics Recent Developments
11.12 uniQure
11.12.1 uniQure Company Details
11.12.2 uniQure Business Overview
11.12.3 uniQure Gene Therapy Drugs Introduction
11.12.4 uniQure Revenue in Gene Therapy Drugs Business (2017-2022)
11.12.5 uniQure Recent Developments
11.13 VBL Therapeutics
11.13.1 VBL Therapeutics Company Details
11.13.2 VBL Therapeutics Business Overview
11.13.3 VBL Therapeutics Gene Therapy Drugs Introduction
11.13.4 VBL Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
11.13.5 VBL Therapeutics Recent Developments
11.14 Voyager Therapeutics
11.14.1 Voyager Therapeutics Company Details
11.14.2 Voyager Therapeutics Business Overview
11.14.3 Voyager Therapeutics Gene Therapy Drugs Introduction
11.14.4 Voyager Therapeutics Revenue in Gene Therapy Drugs Business (2017-2022)
11.14.5 Voyager Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
